35 results on '"Binkley, Michael S."'
Search Results
2. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
3. First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema
4. SOHO State of the Art Updates and Next Questions |Treatment Approaches for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
5. Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents
6. Inferring gene expression from cell-free DNA fragmentation profiles
7. Acute and Late Esophageal Toxicity After SABR to Thoracic Tumors Near or Abutting the Esophagus
8. First in human Phase I Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema
9. Analysis of PET-CT Derived Radiomic Biomarkers with Efficacy, Safety, and Expansion of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL)
10. STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer
11. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
12. Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B‐cell lymphoma in an adolescent patient.
13. Supplementary Figures S1-S7 from The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer
14. Supplementary Table S1 from The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer
15. Data from The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer
16. Abstract 5960: Identification and validation of sarcoma cellular ecosystems associated with prognosis and predictive of immunotherapy response
17. Data from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
18. Supplementary Figures 1-9 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
19. Data from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
20. Supplementary Tables S1-S7 from KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
21. Supplemental Methods from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
22. Supplemental Tables from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
23. Supplemental Figures from Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
24. International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
25. STK11Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer
26. Investigating and modeling positron emission tomography factors associated with large cell transformation from low‐grade lymphomas
27. Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma
28. Characterizing the immune microenvironment for nodular lymphocyte‐predominant Hodgkin lymphoma
29. The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer
30. Investigating and modeling positron emission tomography factors associated with large cell transformation from low‐grade lymphomas.
31. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW)
32. Analysis of PET-CT Derived Radiomic Biomarkers with Efficacy, Safety, and Expansion of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL)
33. Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification
34. Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods
35. Investigating the Cell States and Prognostic Impact of Tumor Microenvironment Ecosystems in Classic Hodgkin Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.